151 related articles for article (PubMed ID: 12804531)
1. Role of monocytes and eosinophils in human respiratory syncytial virus infection in vitro.
Soukup JM; Becker S
Clin Immunol; 2003 Jun; 107(3):178-85. PubMed ID: 12804531
[TBL] [Abstract][Full Text] [Related]
2. Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus.
Olszewska-Pazdrak B; Casola A; Saito T; Alam R; Crowe SE; Mei F; Ogra PL; Garofalo RP
J Virol; 1998 Jun; 72(6):4756-64. PubMed ID: 9573240
[TBL] [Abstract][Full Text] [Related]
3. Airway epithelial cell-induced activation of monocytes and eosinophils in respiratory syncytial viral infection.
Becker S; Soukup JM
Immunobiology; 1999 Sep; 201(1):88-106. PubMed ID: 10532283
[TBL] [Abstract][Full Text] [Related]
4. Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation.
Harrison AM; Bonville CA; Rosenberg HF; Domachowske JB
Am J Respir Crit Care Med; 1999 Jun; 159(6):1918-24. PubMed ID: 10351940
[TBL] [Abstract][Full Text] [Related]
5. Respiratory syncytial virus-induced RANTES production from human bronchial epithelial cells is dependent on nuclear factor-kappa B nuclear binding and is inhibited by adenovirus-mediated expression of inhibitor of kappa B alpha.
Thomas LH; Friedland JS; Sharland M; Becker S
J Immunol; 1998 Jul; 161(2):1007-16. PubMed ID: 9670982
[TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus-infected pulmonary epithelial cells induce eosinophil degranulation by a CD18-mediated mechanism.
Olszewska-Pazdrak B; Pazdrak K; Ogra PL; Garofalo RP
J Immunol; 1998 May; 160(10):4889-95. PubMed ID: 9590236
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus.
Arnold R; Humbert B; Werchau H; Gallati H; König W
Immunology; 1994 May; 82(1):126-33. PubMed ID: 7519169
[TBL] [Abstract][Full Text] [Related]
8. The chemokine RANTES is more than a chemoattractant: characterization of its effect on human eosinophil oxidative metabolism and morphology in comparison with IL-5 and GM-CSF.
Kapp A; Zeck-Kapp G; Czech W; Schöpf E
J Invest Dermatol; 1994 Jun; 102(6):906-14. PubMed ID: 7516398
[TBL] [Abstract][Full Text] [Related]
9. RSV infection of human airway epithelial cells causes production of the beta-chemokine RANTES.
Becker S; Reed W; Henderson FW; Noah TL
Am J Physiol; 1997 Mar; 272(3 Pt 1):L512-20. PubMed ID: 9124609
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome-proliferator-activated receptor-gamma agonists inhibit the release of proinflammatory cytokines from RSV-infected epithelial cells.
Arnold R; König W
Virology; 2006 Mar; 346(2):427-39. PubMed ID: 16330064
[TBL] [Abstract][Full Text] [Related]
11. Quantitative, rather than qualitative, differences in CD69 upregulation in human blood eosinophils upon activation with selected stimuli.
Nopp A; Lundahl J; Halldén G
Allergy; 2000 Feb; 55(2):148-56. PubMed ID: 10726729
[TBL] [Abstract][Full Text] [Related]
12. Effects of respiratory syncytial virus infection and major basic protein derived from eosinophils in pulmonary alveolar epithelial cells (A549).
Ishioka T; Kimura H; Kita H; Obuchi M; Hoshino H; Noda M; Nishina A; Kozawa K; Kato M
Cell Biol Int; 2011 May; 35(5):467-74. PubMed ID: 20977431
[TBL] [Abstract][Full Text] [Related]
13. MAPK activation is involved in posttranscriptional regulation of RSV-induced RANTES gene expression.
Pazdrak K; Olszewska-Pazdrak B; Liu T; Takizawa R; Brasier AR; Garofalo RP; Casola A
Am J Physiol Lung Cell Mol Physiol; 2002 Aug; 283(2):L364-72. PubMed ID: 12114198
[TBL] [Abstract][Full Text] [Related]
14. The GM-CSF analogue E21R induces apoptosis of normal and activated eosinophils.
Iversen PO; Robinson D; Ying S; Meng Q; Kay AB; Clark-Lewis I; Lopez AF
Am J Respir Crit Care Med; 1997 Nov; 156(5):1628-32. PubMed ID: 9372686
[TBL] [Abstract][Full Text] [Related]
15. Procaterol inhibits IL-1beta- and TNF-alpha-mediated epithelial cell eosinophil chemotactic activity.
Koyama S; Sato E; Masubuchi T; Takamizawa A; Kubo K; Nagai S; Isumi T
Eur Respir J; 1999 Oct; 14(4):767-75. PubMed ID: 10573218
[TBL] [Abstract][Full Text] [Related]
16. Multiple cis regulatory elements control RANTES promoter activity in alveolar epithelial cells infected with respiratory syncytial virus.
Casola A; Garofalo RP; Haeberle H; Elliott TF; Lin R; Jamaluddin M; Brasier AR
J Virol; 2001 Jul; 75(14):6428-39. PubMed ID: 11413310
[TBL] [Abstract][Full Text] [Related]
17. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression.
Rudd BD; Burstein E; Duckett CS; Li X; Lukacs NW
J Virol; 2005 Mar; 79(6):3350-7. PubMed ID: 15731229
[TBL] [Abstract][Full Text] [Related]
18. Chemokines and inflammation in the nasal passages of infants with respiratory syncytial virus bronchiolitis.
Noah TL; Ivins SS; Murphy P; Kazachkova I; Moats-Staats B; Henderson FW
Clin Immunol; 2002 Jul; 104(1):86-95. PubMed ID: 12139952
[TBL] [Abstract][Full Text] [Related]
19. The effect of fluticasone propionate on respiratory syncytial virus-induced chemokine release by a human bronchial epithelial cell line.
Noah TL; Wortman IA; Becker S
Immunopharmacology; 1998 Jun; 39(3):193-9. PubMed ID: 9754905
[TBL] [Abstract][Full Text] [Related]
20. The effect of transendothelial migration on eosinophil function.
Yamamoto H; Sedgwick JB; Vrtis RF; Busse WW
Am J Respir Cell Mol Biol; 2000 Sep; 23(3):379-88. PubMed ID: 10970830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
